ImmunoPrecise Antibodies Ltd (IPA)
0.4599
-0.02
(-4.19%)
USD |
NASDAQ |
Nov 14, 16:00
0.50
+0.04
(+8.72%)
After-Hours: 20:00
ImmunoPrecise Antibodies Profit Margin (Quarterly): -75.98% for July 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | -75.98% |
| April 30, 2024 | -279.4% |
| January 31, 2024 | -47.26% |
| October 31, 2023 | -42.63% |
| July 31, 2023 | -60.06% |
| April 30, 2023 | -91.25% |
| January 31, 2023 | -90.87% |
| October 31, 2022 | -141.8% |
| July 31, 2022 | -200.1% |
| April 30, 2022 | -88.64% |
| January 31, 2022 | -79.46% |
| October 31, 2021 | -106.1% |
| July 31, 2021 | -70.40% |
| April 30, 2021 | -103.2% |
| January 31, 2021 | -28.66% |
| October 31, 2020 | -9.76% |
| July 31, 2020 | -14.58% |
| April 30, 2020 | -22.81% |
| January 31, 2020 | -15.51% |
| October 31, 2019 | -43.12% |
| July 31, 2019 | -74.08% |
| April 30, 2019 | -145.5% |
| January 31, 2019 | -44.04% |
| October 31, 2018 | -54.69% |
| July 31, 2018 | -38.37% |
| Date | Value |
|---|---|
| April 30, 2018 | -121.4% |
| January 31, 2018 | -70.31% |
| October 31, 2017 | -68.62% |
| July 31, 2017 | -145.1% |
| April 30, 2017 | -201.3% |
| January 31, 2017 | -868.6% |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-279.4%
Minimum
Apr 2024
-9.76%
Maximum
Oct 2020
-82.55%
Average
-75.98%
Median
Jul 2024
Profit Margin (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 21.17% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -2.12K% |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -61.97% |
| Return on Assets | -39.40% |
| Return on Invested Capital | -61.27% |
| Gross Profit Margin (Quarterly) | 44.77% |
| Operating Margin (Quarterly) | -87.92% |
| Return on Net Operating Assets | -39.45% |